K. Enzweiler

Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.

J. Bosso, D. Hoban, L. Friedrich, 2002, Diagnostic microbiology and infectious disease.

A Novel Method of Estimating Cost of Therapy by Using Patient Population Characteristics: Analysis of Fluoroquinolones in Various Populations with Different Distributions of Renal Function

J. Bosso, Roger L. White, K. Enzweiler, 2003, Pharmacotherapy.

New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 position.

S. Green, K. Wehmeyer, J Chen, 1998, Journal of medicinal chemistry.

New cyclooxygenase-2/5-lipoxygenase inhibitors. 2. 7-tert-butyl-2,3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations of the dihydrobenzofuran ring.

S. Green, K. Wehmeyer, M. Scherz, 1998, Journal of medicinal chemistry.

New cyclooxygenase-2/5-lipoxygenase inhibitors. 1. 7-tert-buty1-2,3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: discovery and variation of the 5-keto substituent.

R. Darolia, S. Green, K. Wehmeyer, 1998, Journal of medicinal chemistry.